G250 Gene specificity expressed in renal cell carcinoma suggest that this antigen be a potential immunotherapeutic target as well as potential target antigen for RCCs vaccines.

• G250在肾细胞癌中的特异性表达使它成为肾癌疫苗潜在的靶抗原和肾癌免疫治疗的重要靶分子。